The company deck in the recent Health Invest presentation still states we are expecting to dose this year.
As every day passes without an ethics submission I'm starting to scratch my head on how likely this is?
Given the transparency and timelines met so far I'm guessing they are confident they can achieve this but it feels like we're starting to cut it real fine.. taking into account things overseas may move quicker, but then there's recruitment etc I would prefer they take their time and get it right of course but if there are to be delays I hope they are communicated early and not at the last minute with cop outs on a technicality.
Hoping to see something soon, otherwise buying opportunity anyone?
(this part in jest)
(20min delay)